Synopsys, Inc. $SNPS Shares Sold by BI Asset Management Fondsmaeglerselskab A S

BI Asset Management Fondsmaeglerselskab A S reduced its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 2.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,661 shares of the semiconductor company’s stock after selling 1,191 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Synopsys were worth $18,897,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of SNPS. Sankala Group LLC purchased a new stake in Synopsys during the 4th quarter valued at about $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new position in Synopsys in the 4th quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd purchased a new position in Synopsys in the 4th quarter worth approximately $28,000. Atlas Capital Advisors Inc. acquired a new position in shares of Synopsys during the 4th quarter worth approximately $32,000. Finally, Phillip James Consulting Co. acquired a new position in shares of Synopsys during the 4th quarter worth approximately $36,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. This represents a 16.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by company insiders.

Synopsys Stock Performance

Synopsys stock opened at $455.51 on Friday. The firm has a 50 day simple moving average of $479.14 and a 200-day simple moving average of $462.05. The stock has a market cap of $87.22 billion, a price-to-earnings ratio of 105.44, a price-to-earnings-growth ratio of 2.68 and a beta of 1.22. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. Synopsys, Inc. has a 1-year low of $376.18 and a 1-year high of $651.73.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the previous year, the company earned $3.67 EPS. The business’s revenue for the quarter was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, analysts expect that Synopsys, Inc. will post 10.65 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. Rosenblatt Securities upped their price target on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research report on Tuesday, May 26th. Stifel Nicolaus boosted their price objective on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Robert W. Baird set a $558.00 target price on Synopsys in a report on Thursday, May 28th. Piper Sandler raised their target price on Synopsys from $430.00 to $450.00 and gave the stock a “neutral” rating in a research note on Thursday, May 28th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $580.00 price target on shares of Synopsys in a report on Thursday, May 28th. Nine analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $563.81.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.